Variant report
Variant | nsv884731 |
---|---|
Chromosome Location | chr6:32307382-32329795 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:38)
- CpG islands (count:1287)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:38 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr6:32309236-32309268 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | BATF | chr6:32313528-32313764 | GM12878 | blood: | n/a | chr6:32313546-32313555 |
3 | CEBPB | chr6:32321136-32321610 | Hela-S3 | cervix: | n/a | n/a |
4 | CTCF | chr6:32317340-32317490 | Caco-2 | colon: | n/a | n/a |
5 | E2F4 | chr6:32311658-32311738 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | EP300 | chr6:32321139-32321500 | Hela-S3 | cervix: | n/a | n/a |
7 | FOS | chr6:32313504-32313882 | MCF10A-Er-Src | breast: | n/a | chr6:32313731-32313742 chr6:32313530-32313539 |
8 | FOS | chr6:32313531-32313873 | MCF10A-Er-Src | breast: | n/a | chr6:32313731-32313742 |
9 | FOS | chr6:32321115-32321505 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | FOS | chr6:32313508-32313881 | MCF10A-Er-Src | breast: | n/a | chr6:32313731-32313742 chr6:32313530-32313539 |
11 | FOS | chr6:32313505-32313875 | HUVEC | blood vessel: | n/a | chr6:32313731-32313742 chr6:32313530-32313539 |
12 | FOS | chr6:32314098-32314129 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOS | chr6:32317500-32317812 | MCF10A-Er-Src | breast: | n/a | chr6:32317643-32317652 |
14 | FOS | chr6:32317508-32317764 | MCF10A-Er-Src | breast: | n/a | chr6:32317643-32317652 |
15 | FOS | chr6:32321184-32321501 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOS | chr6:32321132-32321502 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr6:32317556-32317801 | MCF10A-Er-Src | breast: | n/a | chr6:32317643-32317652 |
18 | FOS | chr6:32321122-32321561 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | GATA2 | chr6:32323035-32323624 | HUVEC | blood vessel: | n/a | n/a |
20 | GATA2 | chr6:32313457-32313814 | HUVEC | blood vessel: | n/a | chr6:32313491-32313502 |
21 | MAFK | chr6:32314185-32314297 | HepG2 | liver: | n/a | n/a |
22 | MAFK | chr6:32327890-32328075 | HepG2 | liver: | n/a | n/a |
23 | MYC | chr6:32310973-32311201 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | MYC | chr6:32321278-32321564 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | NFYA | chr6:32317687-32317810 | Hela-S3 | cervix: | n/a | n/a |
26 | POLR2A | chr6:32317083-32317116 | Gliobla | brain: | n/a | n/a |
27 | POLR2A | chr6:32324354-32324363 | MCF-7 | breast: | n/a | n/a |
28 | POLR2A | chr6:32324969-32325114 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | POLR2A | chr6:32324366-32324388 | MCF-7 | breast: | n/a | n/a |
30 | PRDM1 | chr6:32323220-32323427 | Hela-S3 | cervix: | n/a | n/a |
31 | STAT3 | chr6:32317512-32317778 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | STAT3 | chr6:32321140-32321480 | Hela-S3 | cervix: | n/a | n/a |
33 | STAT3 | chr6:32319840-32319996 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | STAT3 | chr6:32321069-32321546 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | STAT3 | chr6:32321347-32321420 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | STAT3 | chr6:32321165-32321481 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | STAT3 | chr6:32308261-32308444 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | STAT3 | chr6:32321157-32321514 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:32309323-32309373 | AG04450 | lung: | fetal |
2 | chr6:32315772-32315822 | PrEC | prostate: | n/a |
3 | chr6:32324878-32324928 | BE2_C | brain: | n/a |
4 | chr6:32324878-32324928 | PFSK-1 | brain: | n/a |
5 | chr6:32310527-32310577 | GM06990 | blood: | n/a |
6 | chr6:32320715-32320765 | HRPEpiC | eye: | n/a |
7 | chr6:32309323-32309373 | AG04450 | lung: | fetal |
8 | chr6:32315772-32315822 | PrEC | prostate: | n/a |
9 | chr6:32324878-32324928 | BE2_C | brain: | n/a |
10 | chr6:32324878-32324928 | PFSK-1 | brain: | n/a |
11 | chr6:32310527-32310577 | GM06990 | blood: | n/a |
12 | chr6:32320715-32320765 | HRPEpiC | eye: | n/a |
13 | chr6:32320708-32320758 | NH-A | brain: | n/a |
14 | chr6:32308995-32309045 | HL-60 | blood: | n/a |
15 | chr6:32313583-32313633 | HL-60 | blood: | n/a |
16 | chr6:32311517-32311567 | SAEC | small airway: | n/a |
17 | chr6:32320708-32320758 | HNPCEpiC | eye: | n/a |
18 | chr6:32314717-32314767 | SK-N-MC | brain: | n/a |
19 | chr6:32317528-32317578 | GM12878 | blood: | n/a |
20 | chr6:32312513-32312563 | K562 | blood: | n/a |
21 | chr6:32324878-32324928 | GM12878 | blood: | n/a |
22 | chr6:32324878-32324928 | HRCEpiC | kidney: | n/a |
23 | chr6:32317528-32317578 | AG10803 | skin: | n/a |
24 | chr6:32309323-32309373 | PrEC | prostate: | n/a |
25 | chr6:32312351-32312401 | BJ | skin: | n/a |
26 | chr6:32309154-32309204 | BE2_C | brain: | n/a |
27 | chr6:32308995-32309045 | H1-hESC | embryonic stem cell: | embryo |
28 | chr6:32311517-32311567 | A549 | lung: | n/a |
29 | chr6:32314717-32314767 | GM12891 | blood: | n/a |
30 | chr6:32317143-32317193 | PANC-1 | pancreas: | n/a |
31 | chr6:32315253-32315303 | BE2_C | brain: | n/a |
32 | chr6:32317429-32317479 | GM12891 | blood: | n/a |
33 | chr6:32317429-32317479 | IMR90 | lung: | fetal |
34 | chr6:32315253-32315303 | K562 | blood: | n/a |
35 | chr6:32326581-32326631 | HepG2 | liver: | n/a |
36 | chr6:32315772-32315822 | K562 | blood: | n/a |
37 | chr6:32320715-32320765 | SK-N-SH | brain: | n/a |
38 | chr6:32324878-32324928 | Hela-S3 | cervix: | n/a |
39 | chr6:32329440-32329490 | U87 | brain: | n/a |
40 | chr6:32317028-32317078 | AG04450 | lung: | fetal |
41 | chr6:32320715-32320765 | AoSMC | blood vessel: | n/a |
42 | chr6:32315772-32315822 | GM12878 | blood: | n/a |
43 | chr6:32317429-32317479 | HCPEpiC | choroid plexus: | n/a |
44 | chr6:32312351-32312401 | U87 | brain: | n/a |
45 | chr6:32329440-32329490 | A549 | lung: | n/a |
46 | chr6:32313583-32313633 | ProgFib | skin: | n/a |
47 | chr6:32310527-32310577 | ProgFib | skin: | n/a |
48 | chr6:32320708-32320758 | HIPEpiC | eye: | n/a |
49 | chr6:32317028-32317078 | GM12892 | blood: | n/a |
50 | chr6:32309154-32309204 | MCF-7 | breast: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:32312156..32313758-chr6:32316689..32318846,2 | MCF-7 | breast: | |
2 | chr6:32312156..32313758-chr6:32316689..32318846,2 | MCF-7 | breast: | |
3 | chr6:32066051..32069021-chr6:32305851..32308384,2 | K562 | blood: | |
4 | chr6:32297324..32300713-chr6:32303639..32307978,4 | K562 | blood: | |
5 | chr6:32310954..32313823-chr6:32318938..32321332,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-HLA-DRA-6 | chr6:32317289-32317601 | NONHSAT108900 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-603P | TF binding region |
RNU6-603P | CpG island |
ENSG00000223335 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528554394 | chr6:32310004-32310005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540689198 | chr6:32310007-32310008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561964906 | chr6:32310009-32310010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529205962 | chr6:32310066-32310067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191372139 | chr6:32310097-32310098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9268257 | chr6:32310103-32310104 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs3129901 | chr6:32310119-32310120 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs183816080 | chr6:32310167-32310168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs3129902 | chr6:32310194-32310195 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs3129903 | chr6:32310211-32310212 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs188301070 | chr6:32310290-32310291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs3129904 | chr6:32310396-32310397 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs566972048 | chr6:32310403-32310404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs117144699 | chr6:32310404-32310405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs3132955 | chr6:32310415-32310416 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs138908531 | chr6:32310445-32310446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532340067 | chr6:32310479-32310480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539646151 | chr6:32310532-32310533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs117876908 | chr6:32310538-32310539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572966083 | chr6:32310613-32310614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs56016875 | chr6:32310645-32310646 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs9268258 | chr6:32310684-32310685 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs573738805 | chr6:32310714-32310715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9268259 | chr6:32310803-32310804 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs3117136 | chr6:32310811-32310812 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs192786386 | chr6:32310842-32310843 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185268917 | chr6:32310848-32310849 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140179797 | chr6:32310853-32310854 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144049657 | chr6:32310929-32310930 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542844425 | chr6:32310965-32310966 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs9268260 | chr6:32310967-32310968 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs9268261 | chr6:32310986-32310987 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs550572395 | chr6:32311044-32311045 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs569207192 | chr6:32311067-32311068 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs539374406 | chr6:32311089-32311090 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs147358179 | chr6:32311107-32311108 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs114094496 | chr6:32311116-32311117 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs1555117 | chr6:32311148-32311149 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs148394151 | chr6:32311163-32311164 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs116680752 | chr6:32311202-32311203 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs6902224 | chr6:32311213-32311214 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs150952376 | chr6:32311238-32311239 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs577940238 | chr6:32311271-32311272 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs532116317 | chr6:32311272-32311273 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs376161396 | chr6:32311297-32311298 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs545377721 | chr6:32311304-32311305 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs139595484 | chr6:32311356-32311357 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs527917547 | chr6:32311429-32311430 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs3132954 | chr6:32311459-32311460 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs561793076 | chr6:32311503-32311504 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22844521 | CNVD |
Gestational infection | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Encephalopathy | 20692195 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Immune disease | 17576883 | CNVD |
Multiple myeloma | 16616336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:32310000-32311600 | Enhancers | Primary B cells from peripheral blood | blood |
2 | chr6:32310600-32311000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr6:32310800-32311200 | Bivalent Enhancer | GM12878-XiMat | blood |
4 | chr6:32311200-32311800 | Enhancers | GM12878-XiMat | blood |
5 | chr6:32312200-32312600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr6:32312600-32315200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr6:32315000-32315600 | Enhancers | Brain Cingulate Gyrus | brain |
8 | chr6:32315000-32315800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr6:32315200-32315600 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr6:32315200-32316000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr6:32315200-32316000 | Enhancers | Brain Substantia Nigra | brain |
12 | chr6:32315400-32316000 | Enhancers | Brain Angular Gyrus | brain |
13 | chr6:32317400-32317800 | Enhancers | Hela-S3 | cervix |
14 | chr6:32317800-32320800 | Weak transcription | Hela-S3 | cervix |
15 | chr6:32320800-32321800 | Enhancers | Hela-S3 | cervix |
16 | chr6:32320800-32322000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr6:32321800-32323000 | Weak transcription | Hela-S3 | cervix |
18 | chr6:32322000-32323200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr6:32322800-32323600 | Enhancers | HUVEC | blood vessel |
20 | chr6:32323000-32323400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
21 | chr6:32323000-32324200 | Enhancers | Hela-S3 | cervix |
22 | chr6:32323200-32324000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
23 | chr6:32324200-32324600 | Weak transcription | Hela-S3 | cervix |
24 | chr6:32324600-32325600 | Enhancers | Hela-S3 | cervix |
25 | chr6:32325600-32332600 | Weak transcription | Hela-S3 | cervix |